Materias dentro de su búsqueda.
Mostrando 1,121 - 1,140 Resultados de 1,813 Para Buscar '"madre"', tiempo de consulta: 0.18s Limitar resultados
  1. 1121
    “…Neither ASQ3 scores nor MADRS score or socio-economic factors correlated with PRESS or CBCL scores. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mood disorders in children following neonatal hypoxic-ischemic encephalopathy
  2. 1122
    “…MADRS total score and processing speed (but not other cognitive domains) were significant partial mediators of the association between ketamine treatment and improvements in suicidal ideation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
  3. 1123
    “…Esketamine‐treated patients with and without anxiety demonstrated significant reductions in MADRS (mean [SD] change from baseline at day 28: −21.0 [12.51] and −22.7 [11.98], respectively). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder
  4. 1124
    “…The primary outcome was change in MADRS total score at 24 hours and final follow up was at 6 weeks. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of mij821 in patients with treatment-resistant depression: Results from a randomized, placebo-controlled, proof-of-concept study
  5. 1125
    “…Basal TSH levels not correlated with basal MADRS scores, but with higher MADRS scores at week-4 (r=0,415, p=0,031) and at week-8 (r=0,392, p=0,043). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Less basal thyrotropin levels predict antidepressant response in patients with major depression
  6. 1126
    “…Average cost per point change in MADRS score for group 3 versus the control group was dominant (95% CI dominant to Aus $22,585). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial
  7. 1127
    por Gailledreau, J., Gailledreau, B.
    Publicado 2023
    “…For each patient, variation of scores (Delta MADRS/Delta HAM-D) between two consecutive visits were correlated with the average sunshine index observed at noon between these visits. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The sunhine induced placebo effect in Major Depressive Disorder patients exhibits gender differences
  8. 1128
    por Kavakbasi, E., Baune, B. T.
    Publicado 2023
    “…Mean MADRS at 12-months was 19 (38.5 % MADRS reduction). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)
  9. 1129
    por Andrade, Chittaranjan
    Publicado 2011
    “…There was a significant, marked improvement in HAM-D and MADRS scores in each group by the treatment endpoint. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    A 6-week, multicentre, randomized controlled clinical trial to evaluate the safety and efficacy of placeboxetine hydrochloride in the treatment of major depressive disorder in an Indian setting
  10. 1130
    “…Primary efficacy measure was the analysis of the mean change in the Montgomery & Åsberg Depression Rating Scale (MADRS) depression scores, using a non-inferiority test with margin of 1.45. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial
  11. 1131
    “…The study suggests that the PHQ9 and AS-18-D can be useful for measurement of depression severity in an outpatient clinic for affective disorder, while the MADRS shows weak measurement properties for this type of patients.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An item response theory evaluation of three depression assessment instruments in a clinical sample
  12. 1132
    “…Primary endpoint was change from baseline to week 8 in the Montgomery–Åsberg Depression Rating Scale (MADRS) total score analysed by mixed model for repeated measurements, using a noninferiority test followed by a superiority test. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†
  13. 1133
    por Li, Guangjian, Wang, Xu, Ma, Dihui
    Publicado 2016
    “…Moreover, there was a statistically significant reduction from baseline in the MADRS, HAM-D(24), CGI-S, and CGI-I scores with 10 mg vortioxetine vs placebo. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
  14. 1134
    “…Thus, we examined the serum proteome of stroke patients (n = 44, mean age = 63.62 years) and correlated these with the Montgomery–Åsberg Depression Rating Scale (MADRS) scores at 3 months post-stroke. Overall, the patients presented with mild depression symptoms on the MADRS, M = 6.40 (SD = 7.42). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Pathway Proteomic Profile of Ischemic Stroke Survivors Reveals Innate Immune Dysfunction in Association with Mild Symptoms of Depression – A Pilot Study
  15. 1135
    “…RESULTS: Of 37 participants enrolled, 32 (86.5%) completed the study. Baseline mean (SD) MADRS total score was 30.1 (5.1); mean HAM‐A total score was 26.9 (5.0). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
  16. 1136
    “…Primary endpoint was the change in Montgomery-Åsberg Depression Rating Scale (MADRS); secondary endpoints were Clinical Global Impressions-Severity and 17-item Hamilton Depression Rating Scale at week 6. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females
  17. 1137
    “…Low-dose intervals of anaesthetics were associated with increased rates of response (CGI-I: odds ratio 1.22, 95% CI 1.07–1.40, P = 0.004; MADRS-S: odds ratio 1.31, 95% CI 1.09–1.56, P = 0.004) and remission (CGI-S: odds ratio 1.37, 95% CI 1.17–1.60, P ≤ 0.001; MADRS-S: odds ratio 1.31, 95% CI 1.10–1.54, P = 0.002). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effect of anaesthetic dose on response and remission in electroconvulsive therapy for major depressive disorder: nationwide register-based cohort study
  18. 1138
    “…In patients with depression, the mean MADRS total score decreased from 26.3 ± 4.4 at baseline to 11.1 ± 8.9 at 8 weeks, a reduction of 57.8%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recognition of Facial Emotion Expressions in Patients with Depressive Disorders: A Prospective, Observational Study
  19. 1139
    “…METHODS: This was a post hoc analysis of data from an 8-week, randomized, double-blind, placebo-controlled, Phase 3 study of vortioxetine (10 mg or 20 mg) in Japanese patients aged 20–75 years with recurrent MDD and a Montgomery–Åsberg Depression Rating Scale (MADRS) score of at least 26. Changes from baseline to week 8 in MADRS total score and Hamilton Depression Rating Scale (HAM-D) anxiety/somatization factor score were assessed in patients with anxious depression (HAM-D anxiety/somatization factor score ≥7) and without anxious depression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
  20. 1140
    “…The primary outcome was the number of ECT treatments required to achieve a 50% reduction in the Montgomery-Asberg Depression Rating Scale (MADRS). Secondary outcomes included the number of ECT treatments required to achieve a 25% reduction in MADRS score, as well as any differences in the Clinical Global Impression Scale for Severity, hemodynamic variables, and seizure duration. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy: a randomized controlled trial
Herramientas de búsqueda: RSS